sellWeak cluster of 5
Elsbernd Brian sold $287k of CPRX
Chief Compliance/Legal Officer at CATALYST PHARMACEUTICALS, INC.. 13,256 shares at an average of $21.63, traded Nov 26, 2024, filed Nov 29, 2024.
Warning score
29Value
$287k
13,256 shares
Holdings after
171,177
-8% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001161697-24-000490, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 26, 2024 | MOption exercise Common Stock, par value $0.001 per share | +50,244 | $4.01 | $201k | 174,677 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale Common Stock, par value $0.001 per share | -9,300 | $21.65 | $201k | 165,377 | Nov 29, 2024 |
| Nov 26, 2024 | MOption exercise Common Stock, par value $0.001 per share | +9,756 | $4.01 | $39k | 175,133 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale Common Stock, par value $0.001 per share | -3,956 | $21.58 | $85k | 171,177 | Nov 29, 2024 |
| Nov 26, 2024 | MOption exercise Options to Purchase Common Stockderivative | -50,244 | $0.00 | $0 | 1,104,766 | Nov 29, 2024 |
| Nov 26, 2024 | MOption exercise Options to Purchase Common Stockderivative | -9,756 | $0.00 | $0 | 1,095,010 | Nov 29, 2024 |
Related signals
Other insiders at CATALYST PHARMACEUTICALS, INC. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 40Moderate | sell 4 | CPRX CATALYST PHARMACEUTICALS, INC. | Miller Steve Chief Op. & Scientific Officer | $1.1M | 50,000 | |
| 51Moderate | sell 5 | CPRX CATALYST PHARMACEUTICALS, INC. | Harper Molly director | $385k | 17,500 | |
| 33Weak | sell 5 | CPRX CATALYST PHARMACEUTICALS, INC. | INGENITO GARY Chief Med. & Reg. Officer | $273k | 12,000 | |
| 47Moderate | sell 4 | CPRX CATALYST PHARMACEUTICALS, INC. | INGENITO GARY Chief Med. & Reg. Officer | $806k | 38,000 | |
| 40Moderate | sell 4 | CPRX CATALYST PHARMACEUTICALS, INC. | MCENANY PATRICK J director, other | $3.6M | 170,845 | |
| 40Moderate | sell 4 | CPRX CATALYST PHARMACEUTICALS, INC. | MCENANY PATRICK J director, other | $3.1M | 137,155 | |
| 38Weak | sell 2 | CPRX CATALYST PHARMACEUTICALS, INC. | MCENANY PATRICK J director, other | $12M | 492,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.